Response to Letters Regarding Article, "Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study"

被引：0
|
作者：
Guazzi, Marco [1 ]
Vicenzi, Marco [1 ]
Arena, Ross [2 ]
Guazzi, Maurizio D. [3 ]
机构：
[1] Univ Milan, Cardiopulm Unit, Milan, Italy
[2] Univ New Mexico, Dept Phys Therapy, Albuquerque, NM 87131 USA
[3] Univ Milan, Dept Cardiol, Milan, Italy
来源：
CIRCULATION | 2012年 / 125卷 / 08期
关键词：
D O I：
10.1161/CIRCULATIONAHA.111.072090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E409 / E410
页数：2
相关论文
共 50 条
  • [41] H2FPEF score predicts 1-year rehospitalisation of patients with heart failure with preserved ejection fraction
    Tao, Yifei
    Wang, Wenjing
    Zhu, Jing
    You, Tao
    Li, Yi
    Zhou, Xiang
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1145) : 164 - 167
  • [42] Renal function deterioration and 1-year mortality in patients with acute decompensated heart failure and preserved or reduced ejection fraction
    Zairis, M.
    Patsourakos, A.
    Adamopoulou, E.
    Georgilas, A. Theodosis
    Benopoulos, A.
    Garefalakis, K.
    Smilakos, P.
    Makrygiannis, S.
    Katsaros, K.
    Foussas, S.
    EUROPEAN HEART JOURNAL, 2010, 31 : 574 - 574
  • [43] SGLT2 Inhibition Ameliorates Exercise-Induced Pulmonary Hypertension (EIPH) in Heart Failure with Preserved Ejection Fraction
    Satoh, T.
    Wang, L.
    Levine, A.
    Baust, J.
    Lai, Y.
    Wyman, S.
    Wu, Y.
    McTieman, C. F.
    Gladwin, M. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [44] Letter by Guazzi Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study"
    Guazzi, Marco
    CIRCULATION, 2015, 132 (13) : E160 - E160
  • [45] Endothelin 1 Is Associated with Heart Failure Hospitalization and Long-Term Mortality in Patients with Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension
    Chowdhury, Mohammed Andaleeb
    Moukarbel, George V.
    Gupta, Rajesh
    Frank, Stephanie Marie
    Anderson, Ann M.
    Liu, Lijun C.
    Khouri, Samer J.
    CARDIOLOGY, 2019, 143 (3-4) : 124 - 133
  • [46] Response to the letter regarding the article 'Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction'
    Kresoja, Karl-Patrik
    Rommel, Karl-Philipp
    Thiele, Holger
    Lurz, Philipp
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04)
  • [47] Phosphodiesterase 5 Inhibitor Therapy Improves Clinical Parameters in Patients With Heart Failure With Preserved Ejection Fraction and Combined Post- and Pre-capillary Pulmonary Hypertension
    Kramer, Tilmann T.
    Orlova, Kristina
    Gerhardt, Felix
    Dumitrescu, Daniel
    ten-Freyhaus, Henrik
    Baldus, Stephan
    Rosenkranz, Stephan
    CIRCULATION, 2017, 136
  • [48] Pulmonary Vasculature Responsiveness to Phosphodiesterase-5A Inhibition in Heart Failure With Reduced Ejection Fraction: Possible Role of Plasma Potassium
    Monzo, Luca
    Reichenbach, Adrian
    Al-Hiti, Hikmet
    Jurcova, Ivana
    Huskova, Zuzana
    Kautzner, Josef
    Melenovsky, Vojtech
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [49] Effects of CD34+Cell Therapy in Heart Failure With Preserved Ejection Fraction: 1-Year Follow-Up
    Vrtovec, Bojan
    Frljak, Sabina
    Zemljic, Gregor
    Poglajen, Gregor
    Cerar, Andraz
    Jaklic, Martina
    Haddad, Francois
    CIRCULATION, 2018, 138
  • [50] Letter by Wang et al Regarding Article, "Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction"
    Wang, Daxin
    Mao, Yongqing
    Wang, Ti
    Xiong, Ting
    Yang, Xinquan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (09) : E260 - E261
12345